57
Views
5
CrossRef citations to date
0
Altmetric
Short communication

AZT 5′-triphosphate nanoformulation suppresses human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells

, &
Pages 343-347 | Received 09 Apr 2009, Published online: 27 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

David Lembo, Manuela Donalisio, Andrea Civra, Monica Argenziano & Roberta Cavalli. (2018) Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections. Expert Opinion on Drug Delivery 15:1, pages 93-114.
Read now
Violeta Rodriguez-Ruiz, Andrei Maksimenko, Resmi Anand, Sandra Monti, Valentina Agostoni, Patrick Couvreur, Maria Lampropoulou, Konstantina Yannakopoulou & Ruxandra Gref. (2015) Efficient “green” encapsulation of a highly hydrophilic anticancer drug in metal–organic framework nanoparticles. Journal of Drug Targeting 23:7-8, pages 759-767.
Read now
Abeer M Al-Ghananeem, Michael Smith, Maria L Coronel & Hieu Tran. (2013) Advances in brain targeting and drug delivery of anti-HIV therapeutic agents. Expert Opinion on Drug Delivery 10:7, pages 973-985.
Read now
Shadabul Haque, Shadab Md, Md. Intekhab Alam, Jasjeet K. Sahni, Javed Ali & Sanjula Baboota. (2012) Nanostructure-based drug delivery systems for brain targeting. Drug Development and Industrial Pharmacy 38:4, pages 387-411.
Read now
Zainulabedin M Saiyed, Nimisha H Gandhi & Madhavan PN Nair. (2010) Magnetic nanoformulation of azidothymidine 5’-triphosphate for targeted delivery across the blood–brain barrier. International Journal of Nanomedicine 5, pages 157-166.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.